Begin main content

Omalizumab

Last Updated: September 22, 2014
Result type: Reports
Project Number: SR0398-000
Product Line: Common Drug Review

Generic Name: Omalizumab

Brand Name: Xolair

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Indications: Urticaria, chronic idiopathic

Submission Type: New Indication

Project Status: Complete

Date Recommendation Issued: May 7, 2015

Recommendation Type: List with clinical criteria and/or conditions